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Abstract
Background:  The different sensory modalities temperature, pain, touch and muscle
proprioception are carried by somatosensory neurons of the dorsal root ganglia. Study of this
system is hampered by the lack of molecular markers for many of these neuronal sub-types. In
order to detect genes expressed in sub-populations of somatosensory neurons, gene profiling was
carried out on wild-type and TrkA mutant neonatal dorsal root ganglia (DRG) using SAGE (serial
analysis of gene expression) methodology. Thermo-nociceptors constitute up to 80 % of the
neurons in the DRG. In TrkA mutant DRGs, the nociceptor sub-class of sensory neurons is lost
due to absence of nerve growth factor survival signaling through its receptor TrkA. Thus,
comparison of wild-type and TrkA mutants allows the identification of transcripts preferentially
expressed in the nociceptor or mechano-proprioceptor subclasses, respectively.
Results: Our comparison revealed 240 genes differentially expressed between the two tissues (P
< 0.01). Some of these genes, CGRP, Scn10a are known markers of sensory neuron sub-types.
Several potential markers of sub-populations, Dok4, Crip2 and Grik1/GluR5 were further analyzed
by quantitative RT-PCR and double labeling with TrkA,-B,-C, c-ret, parvalbumin and isolectin B4,
known markers of DRG neuron sub-types. Expression of Grik1/GluR5 was restricted to the
isolectin B4+ nociceptive population, while Dok4 and Crip2 had broader expression profiles. Crip2
expression was however excluded from the proprioceptor sub-population.
Conclusion: We have identified and characterized the detailed expression patterns of three genes
in the developing DRG, placing them in the context of the known major neuronal sub-types defined
by molecular markers. Further analysis of differentially expressed genes in this tissue promises to
extend our knowledge of the molecular diversity of different cell types and forms the basis for
understanding their particular functional specificities.
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Background
The primary receptor cells of the somatosensory system
are the neurons of the dorsal root ganglia (DRG). Their
role is to detect environmental stimuli such as noxious
stimuli, temperature, mechanical pressure, propriocep-
tion and to conduct these signals to the central nervous
system. Noxious stimuli are sensed by nociceptors that
innervate the skin, muscle and internal organs. Touch and
proprioceptive stimuli are detected by low-threshold
mechanoreceptors that innervate the skin and muscle,
respectively.
There exist up to 20 different sub-types of sensory neurons
in the DRG [1]. Different sub-types can be distinguished
by a variety of criteria: cell body diameter; conduction
velocity; neurotrophic factor dependence; sensitivity to
specific stimuli; expression of neuropeptides, ion chan-
nels, calcium-binding proteins and transcription factors
[2]. However, for many sub-types no specific molecular
markers have been found. For example, slowly adapting
mechanoreceptors [SAMs] that interact with Merkel cells
in the skin and whose phenotypic development depends
on BDNF/TrkB signaling [3] can only be identified using
physiological criteria. Thus identification of specific
molecular markers is an essential step in understanding
the development and the function of this system. A large
body of evidence shows that nociceptors depend for their
survival during development on NGF signaling through
TrkA receptors specifically expressed on these cells [4-6].
TrkA mutant mice are insensitive to painful stimuli and
mutations in TRKA are associated with the syndrome
"Congenital insensitivity to pain" in humans [7]. Around
the time of birth, nociceptors divide into 2 main popula-
tions, one of which maintains TrkA expression and
secretes neuropeptides such as CGRP and substance P.
The other population down-regulates TrkA, expresses the
Ret tyrosine kinase receptor and requires GDNF for its sur-
vival [8]. This non-peptidergic population is further char-
acterized by the capacity of binding the lectin IB4 and it
has recently been shown that the transcription factor
Runx1 is necessary for the phenotypic development of this
cell population [9]. In the adult mouse, peptidergic (TrkA
expressing) and non-peptidergic (c-Ret expressing) nocic-
eptors project to the different laminae in the dorsal horn,
and may be responsible for different pain modalities
(reviewed in [10]). Skin mechanoreceptors and muscle
proprioceptors depend for their survival on NT-3, BDNF
and NT-4 and project to deeper laminae in the spinal
cord, reviewed in [2].
To study the physiology of somatosensory neurons and
the molecular changes in functionally-identified DRG
neuron sub-types during development and after periph-
eral trauma, we have created several SAGE (serial analysis
of gene expression) libraries from DRG tissues [11]. SAGE
generates global gene expression data from thousands of
transcripts in a given tissue or cell-type [12]. Since nocice-
ptors constitute up to 80% of all neurons in the DRG,
transcripts representing this cell type should be enriched
in wild-type tissue. TrkA mutant mice lose all nociceptive
neurons during development due to inactivation of the
NGF survival signaling pathway [4,6], leaving only TrkB
and TrkC mechanoreceptor neurons, thus the TrkA
mutant DRG is enriched for transcripts representing low-
threshold myelinated mechanoreceptors. In the study pre-
sented here, we compared the transcription profiles of
wild-type and TrkA mutant DRG from neonatal mice in
order to identify markers of sub-populations. Double
labeling analysis of a selection of these genes with known
markers of DRG neuron sub-types revealed expression in
sub-populations of DRG neurons in the adult mouse from
birth to adulthood.
Results
General results from SAGE libraries analysis
We used SAGE technology to generate global gene expres-
sion profiles from wild-type and TrkA mutant DRGs. This
methodology consists in isolating, from a given cDNA
preparation, short 14-bp tags which are small nucleotides
sequences representative of a particular transcript [12].
Sequencing and counting of tags generates information
about the presence and frequency of thousands of tran-
scripts in the original tissue. One thousand plasmid
inserts were sequenced for each library, resulting in
27,543 and 31,591 tags for the wild-type and the mutant
DRG libraries, respectively. The overall results of the bio-
informatics analysis are shown in Figure 1.
Differential analysis of P0 WT versus P0 TrkA mutant mice 
libraries
Tag frequencies were compared between the WT and TrkA
mutant SAGE libraries in order to identify genes preferen-
tially expressed in one or the other tissues. This analysis
revealed that 240 genes are differentially expressed (P <
0.01) between the two banks including 151 tags more
highly expressed in wild type library and 89 tags more rep-
resented in mutant mice library, and might represent new
markers of subpopulations of DRG neurons. A prelimi-
nary analysis of 20 genes, chosen on the basis of differen-
tial Tag numbers, was carried out by whole-mount in situ
hybridisation on P0 dorsal root ganglia (not shown). Sub-
sequently we analyzed, by in situ hybridisation on cryo-
stat sections, three genes chosen on the basis of restricted
expression pattern and published information about their
potential function. Crip2 (Cysteine-rich intestinal protein
2, [GenBank:NM_024223] is an intracellular adaptor pro-
tein that may interact with actin cytoskeleton [13] and has
never been described in the DRG. Dok4 (Downstream of
tyrosine kinase/Docking proteins, [Gen-
Bank:NM_053246] has been reported in embryonic DRGBMC Neuroscience 2007, 8:97 http://www.biomedcentral.com/1471-2202/8/97
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neurons without specifying what sub-population and is
thought to play a role in receptor tyrosine kinase signal-
ling pathways [14]. Grik1 alias GluR5 (Glutamate recep-
tor, ionotropic, kainate 1, [GenBank:NM_146072] is a
glutamate receptor that has been associated with P2X3-
expressing non-peptidergic nociceptors in the DRG [15].
Pharmacological studies [16] and analysis of Grik1/
GluR5 knockout mice [17] show a role for this molecule
in nociception. The SAGE results for these 3 genes as well
as for several markers of sensory neuron populations are
shown in the Supplementary Table [18]. These genes were
further studied in detail by quantitative RT-PCR and in
situ hybridisation.
Quantitative PCR on selected genes
For the 3 chosen genes we carried out quantitative RT-PCR
on mRNA extracted from wild-type and TrkA mutant DRG
tissue dissected at P0. Grik1/GluR5, Dok4 and Crip2 tran-
scripts were less abundant in TrkA mutant DRG compared
to wild-type; relative normalized expression levels were
respectively 1.04 +/- 0.12; 1.10 +/- 0.13; 1.13 +/- 0.16 in
wild-type and 0.06 +/- 0.01; 0.29 +/- 0.05; 0.30 +/- 0.04 in
Trk A mutant mice (Figure 2). These quantitative RT-PCR
(A) Numbers of sequenced tags and different tags for each library Figure 1
(A) Numbers of sequenced tags and different tags for each library. (B) Scatter plot showing a comparative expression level of 
tags between P0 WT and TrkA mutant. The occurrence of each tag was plotted on a logarithmic scale (tags with no expression 
in one library were set to a value of one). A color is attributed to the tag according to the significance of the P value. Differently 
expressed tags (P < 0.01) are encircled.BMC Neuroscience 2007, 8:97 http://www.biomedcentral.com/1471-2202/8/97
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results confirmed the data obtained from the SAGE tag
analysis. When expressed as "fold-change in expression"
the SAGE results demonstrate a down regulation of Grik1,
Dock4 and Crip2 expression between P0 WT and P0 Trka-
/- DRG of about 18, 6 and 3 fold respectively, while QRT-
PCR provided an expression ratio between P0 WT and P0
Trka-/- DRG of 17, 4 and 4 fold respectively.
In situ hybridization patterns of selected genes
In order to assess the types of cells in which the candidate
genes were expressed and to gain idea about the potential
expression in functional sub-types, we carried out in situ
hybridization on sections of wild-type or mutant ganglia
using DIG-labelled probes generated from PCR products
amplified using primers specific for each gene. In all cases
the PCR products were sequenced to confirm the identity
of the probe. Figure 3 shows the in situ hybridization pro-
file for these transcripts on cryostat sections from wild-
type P0, TrkA mutant and adult DRGs. As controls we
used riboprobes generated against TrkA, the neuropeptide
CGRP and the sodium channel Scn10a, all known mark-
ers of nociceptive neurons. As shown in Figure 3(A–I) ,
TrkA, CGRP and Scn10a all label sub-populations of neu-
rons in P0 wild-type and adult DRGs. In accordance with
the loss of nociceptive neurons in TrkA mutant DRGs, no
labelling for these transcripts was observed in TrkA
mutant DRGs (Figure 3B, E, H).
Transcripts representing the adaptor protein Dok4 were
observed in broad range of neuron-like cells in wild-type
P0 and adult DRG (95% +/- 0.9 of all neurons), with neg-
ative cells scattered throughout the tissue (arrows in Fig-
ure 3L). Labelled cells were also observed in TrkA mutant
DRG sections from new-born mice (Figure 3K).
Crip2 was expressed in a large proportion (86% +/- 1) of
cells of neuronal morphology in the P0 wild-type and
adult DRG (Figure 3M, O). However, unlabeled cells were
observed. In P0 TrkA mutant DRG, a number of Crip2
labelled cells were observed (Figure 3N), suggesting that
the expression of this gene is not exclusive to the nocicep-
tor population. Crip2 expression persisted in adult DRG,
and negative cells of large cell diameter were observed
(Figure 3O, arrows).
The kainate receptor Grik1/GluR5 was expressed in a sub-
population of cells of neuronal morphology in wild-type
DRG and was completely absent in TrkA mutant DRG,
strongly suggesting nociceptor specific expression (Figure
3P, Q, R). Grik1/GluR5 expression persisted in a sub-pop-
ulation of cells (37% +/- 1.3 of all neurons) in the adult
(Figure 3R).
Sub-population specific expression pattern revealed by 
double labeling
To further characterise the sub-population in which the
genes of interest were expressed, we carried out double
labelling using known markers of neuronal DRG sub-
populations (Figure 4).
Grik1/GluR5 expression was absent from each of the
TrkA, TrkB and TrkC expressing populations (Figure 4C, F,
I). However, Grik1/GluR5 was expressed in a sub-popula-
tion (73 % +/- 0.8) of neurons of small cell body diameter
labelled by c-Ret (Figure 4L). These cells correspond to the
isolectin B4 positive nociceptor population as shown by
double labelling where there was 87 % +/- 0.3 co-localisa-
tion of Grik1/GluR5 and isolectin B4 (Figure 4O). Virtu-
ally all Grik1/GluR5-expressing neurons were IB4-
positive.
Dok4 was expressed in a wide range (95 % +/- 0.9) of neu-
rons of different cell diameters in the adult DRG. In co-
localisation studies we observed that most neurons
expressing members of the Trk receptor family also
expressed Dok4. In addition, most c-ret and isolectin B4+
neurons also expressed Dok4 (Figure 5A–D). However,
we consistently observed that about 5% of all cells with
neuron-like morphology were negative for Dok4. In co-
labeling experiments with Trks, c-ret and IB4 lectin, it was
observed that these Dok4 negative cells were never
labelled by any of the 5 markers used.
Most TrkA-expressing neurons were also Crip2-positive, as
were TrkB and c-ret expressing neurons (Figure 5E–H).
QRT-PCR: Gene expression determined by real-time PCR  on P0 and P0 TrkA mutant mouse lumbar DRG Figure 2
QRT-PCR: Gene expression determined by real-time PCR 
on P0 and P0 TrkA mutant mouse lumbar DRG. TrkA and 
Ube2e3 (ubiquitin-conjugating enzyme E2E 3) were used as 
controls. Data (means ± SEM) were calculated by the delta-
CT method [37] on three independent experimental repli-
cates. The arithmetic means of the expression levels of two 
genes (Polr2j, Ddx48) whose expression do not change in 
the course of development and in TrkA-/- DRG were used 
to normalize the expression levels. Data were analyzed using 
the Mann Whitney U-test (*P < 0.05). ND: Not detected.BMC Neuroscience 2007, 8:97 http://www.biomedcentral.com/1471-2202/8/97
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In situ hybridization patterns of selected genes Figure 3
In situ hybridization patterns of selected genes: In situ hybridization on cryostat section of P0 Wild type (A, D, G, J, M, 
P), P0 TrkA mutant (B, E, H, K, N, Q) and adult (C, F, I, L, O, R) with DIG-labelled probes for TrkA (A, B, C); Scn10a (D, E, F); 
CGRP (G, H, I); Dok4 (J, K, L); Crip2 (M, N, O) and Grik1/GluR5 (P, Q, R). Arrows in L and O indicate unlabelled cells. TrkA 
mutant DRGs are encircled in B, E, H, K, N and Q. Data show that Dok4 was expressed in the majority of neurons, scattered 
negative cells was observed, arrows in L. Crip2 was widely expressed, although substantial numbers of negative cells were 
noted, arrows in O. Grik1/GluR5 was expressed in sub-population of neurons and was completely absent from TrkA mutant 
DRG. Scale bar 50 µm.BMC Neuroscience 2007, 8:97 http://www.biomedcentral.com/1471-2202/8/97
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Co-localisation Grik1/GluR5 mRNA with markers of defined sub-populations of sensory neurons Figure 4
Co-localisation Grik1/GluR5 mRNA with markers of defined sub-populations of sensory neurons: Double in situ 
hybridization was carried out on sections of adult DRG by using fluorescein/fast red detection for TrkA (A), TrkB (D), TrkC 
(G), c-ret (J) and immunohistochemical detection of isolectin B4 (M). Grik1/GluR5 mRNA was subsequently detected using 
DIG/NBT-BCIP detection in B, E, H, K, N. In situ signals were converted into pseudo colors and images were superimposed 
(C, F, I, L, O) to show co-labelling of cells. Grik1/GluR5 was excluded from TrkA, B and C population but was co-localised with 
c-ret and isolectin B4 neurons. Scale bar 50 µm.BMC Neuroscience 2007, 8:97 http://www.biomedcentral.com/1471-2202/8/97
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However, all TrkC expressing neurons were negative for
Crip2 (Figure 5G), and as expected, Crip2 was never co-
localised with parvalbumin, a definitive marker of muscle
proprioceptors (data not shown).
Discussion
In this report we describe the use of a combination of
SAGE analysis and in situ hybridization to identify mark-
ers of sensory neuron sub-types in the dorsal root gan-
glion of the mouse. We took advantage of the fact that in
the TrkA mutant mouse all neurons of the nociceptive
sub-type die during development. By creating SAGE banks
from wild-type (> 75% nociceptive) and TrkA mutant
(100% mechanosensitive and proprioceptive) we could
compare global expression profiles of the 2 major classes
of neurons in the DRG i.e. mainly non-myelinated or
thinly-myelinated nociceptors and myelinated low-
threshold mechanoreceptors of skin and muscle. The
choice of the developmental time-point P0 was deter-
mined by the fact that TrkA mutant mice die in the days
following birth, and that we are interested in identifying
molecules involved in the functioning of DRG neurons in
the maturing somatosensory system. Although the start-
ing material, whole DRG, necessarily contains non-neuro-
nal cells including satellite glia and immature Schwann
cells, methods based on isolating purified neurons in cul-
ture were considered to be overly artificial, since the cul-
tured neurons undergo axotomy during dissection.
We carried out more detailed analysis of a limited sample
of these genes, whose exact sub-population specificity had
not previously been determined, by QRT-PCR and double
labeling using known markers of sensory neuron sub-
populations. In each case, the SAGE results were con-
firmed by quantitative RT-PCR.
Co-localisation of Crip2 and Dok4 mRNAs with defined sub-populations of sensory neurons Figure 5
Co-localisation of Crip2 and Dok4 mRNAs with defined sub-populations of sensory neurons: Double in situ 
hybridization was carried out by using fluorescein/fast red detection for TrkA (A, E), TrkB (B, F), TrkC (C, G), c-ret (D, H) and 
DIG/NBT-BCIP for Dok4 (A, B, C, D) and Crip2 (E, F, G, H). In situ signals were converted into pseudo colors and images 
were superimposed to show co-labelling of cells. Dok4 co-localised with all major subtypes of DRG neurons, Crip2 was specif-
ically excluded from TrkC population. Scale bar 50 µm.BMC Neuroscience 2007, 8:97 http://www.biomedcentral.com/1471-2202/8/97
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Qualitatively, we observed three types of in situ hybridiza-
tion expression patterns. For Dok4 there is a quantitative
difference in expression, while the double in situ hybridi-
zation pattern does not reveal remarkable sub-population
specificity of expression. We can suggest that while Dok4
is expressed in most neurons, expression is generally
higher in the nociceptive population. However, it cannot
be ruled out that the basal expression level of this gene is
changed in the surviving neurons of the TrkA mutant
DRG. Downstream of tyrosine kinase/Docking proteins
(Dok) comprise a family of intracellular adaptors that
modulate signaling pathways mediated by receptor and
non-receptor tyrosine kinases. For example Dok7 regu-
lates neuromuscular junction formation by interaction
with MuSK [19]. In biochemical studies, it was shown that
Dok5 could interact specifically with TrkB and TrkC recep-
tors, but not TrkA, and was involved in neurotrophin
induced MAPK activation [20]. Dok4 was shown to regu-
late GDNF/Ret dependent neurite outgrowth in neurob-
lastoma cells [21]. Expression of Dok4 has been described
in the DRG during embryonic development, and an inter-
action with c-Ret was demonstrated in a heterologous cell
expression system [14]. Our results show that, in adult
DRG, Dok4 is expressed in Ret-expressing neurons, but
the broad expression of this molecule suggests a potential
role in association with other tyrosine kinase receptors.
Interestingly, about 5% of adult DRG neurons were Dok-
negative and these cells did not express any of the 4 typical
DRG neuron tyrosine kinase receptors (trks A, B, C, c-ret),
suggesting that there might be an as yet unidentified sub-
population that uses a ligand receptor signaling system
other than Trks or Ret. This observation is in line with the
study of Kashiba et al., [22] who showed, using a cocktail
of in situ hybridization probes for the Trks and Ret recep-
tors, that a small proportion (3%) of neurons remained
unlabeled.
Our results show for the first time that Crip2 is expressed
in DRG neurons. Intriguingly, this molecule is very specif-
ically excluded from the TrkC-expressing population that
includes the parvalbumin expressing proprioceptors [23]
and certain low-threshold mechanoreceptors [24]. Thus it
is possible that this gene is negatively regulated by TrkC
signaling. On the other hand, it has been shown that the
transcription factor RunX3 plays an essential role in the
establishment of the proprioceptive neuron phenotype
[25] and the targeting of proprioceptive (TrkC-expressing)
afferents to the ventral region of the spinal cord [9], rais-
ing the possibility that Crip2 expression is under the con-
trol of this transcriptional program. The cysteine-rich LIM-
only protein Crip2 is a member of a family of related pro-
teins, Crip1, Crip2 and TLP/Crip3 [13,26,27]. These pro-
teins contain 1 or 2 LIM domains and are thought to act
as intracellular adaptors, although the signaling path-
way(s) involved have not been identified. The expression
of Crip2 has been described in developing and adult mes-
enchymal tissue and in particular in the developing and
adult heart [26]. An interaction between Crip2 and the
mouse protein tyrosine phosphatase PTP-BL [13] was
demonstrated by 2-hybrid screen, and it was proposed
that Crip2/PTP-BL interactions might play a role in the
dynamics of the actin cytoskeleton. The functional signif-
icance of Crip2 expression in DRG neurons remains to be
explored, Concerning Grik1/GluR5, our results show une-
quivocally that, in the adult mouse DRG, this kainate
receptor is expressed in the great majority of isolectin B4
binding neurons and is excluded from other neuronal
sub-types. A body of evidence shows that Grik1/Glur5
receptors are expressed in sensory neurons of the DRG
and are transported to the spinal cord where they are an
essential component of presynaptic kainate receptors
thought to play a role in the modulation of pain sensation
[28]. Grik1/GluR5 mutant mice display altered behavioral
responses to noxious stimuli [17]. Several studies have
indirectly pointed to a localization of Grik1/GluR5 in the
isolectin B4 binding DRG neuron sub-population. By
pharmacological experiments on cultured neonatal rat
DRG neurons, Grik1/GluR5 was identified in isolectin B4
binding cells [29] and was shown by double immunhisto-
chemistry to be highly-represented in the P2X3 positive
nociceptor population, that are mostly isolectin B4 bind-
ing [15]. In previous studies, using in situ hybridization,
the expression of Grik1/GluR5 was detected in mouse
DRG from E12 onward, using a rat probe on mouse tissue
[30], and by RT-PCR in E16 rat DRG tissue [29]. In our
experiments on mouse tissue, by both QRT-PCR and in
situ hybridization, we could not detect this mRNA at 2
time-points prior to birth, E13 and E15 (data not shown).
This discrepancy may be due to the use of cross-species
probes in the earlier study, or the fact that earlier in situ
studies used more sensitive radioactive in situ technique.
Nevertheless, our in situ hybridization and QRT-PCR
results suggest that high Grik1/GluR5 expression appears
at the late embryonic phase. At P0, Grik1/GluR5 was
largely co-localized with c-ret (data not shown). In the
adult, Grik1/GluR5 never co-localized with TrkA and was
restricted to small cell-diameter c-Ret+/isolectin B4+ neu-
rons. Thus Grik1/GluR5 expression seems to coincide
with the appearance of the population of nociceptors that
down-regulate TrkA and express c-Ret and bind isolectin
B4 [8]. This switch in expression also parallels that of
Runx1, a transcription factor that is broadly co-localized
with TrkA at P0, and whose expression becomes restricted
to the isolectin B4+ nociceptor population during early
postnatal life [31]. Indeed, Runx1 appears to regulate the
molecular phenotype of this cell-type as demonstrated by
the analysis of Runx1 mutant mice, in which was observed
an expansion of the TrkA/peptidergic nociceptor pheno-
type and a lack of expression of a range of genes normally
expressed in the non-peptidergic/IB4+ nociceptor popula-BMC Neuroscience 2007, 8:97 http://www.biomedcentral.com/1471-2202/8/97
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tion [31]. Runx1 mutant mice display loss of sensitivity to
acute thermal, but not mechanical, pain stimuli, as well as
reduced responses to inflammatory stimuli [31] a pheno-
type partially mirrored by that of the Grik1/GluR5 mutant
[17]. Our results suggest that Grik1/GluR5 could be a tar-
get gene of Runx1 and should play a role in the specific
functions of these neurons.
Conclusion
In conclusion, we have identified and characterized the
detailed expression patterns of three genes in the develop-
ing DRG, placing them in the context of the known major
neuronal sub-types as defined by several molecular mark-
ers. Further analysis of differentially expressed genes in
this tissue promises to extend our knowledge of the
molecular diversity of different cell types and forms the
basis for understanding their particular functional specif-
icities.
Methods
Animals
Procedures involving animals and their care were con-
ducted in agreement with the French Ministry of Agricul-
ture and the European Community Council Directive no.
86/609/EEC, OJL 358, 18 December 1986. Early post-
natal (P0) mice, were killed by decapitation. Adult mice
were deeply anaesthetized with CO2 and then decapi-
tated. Lumbar L3-L6 DRG for P0 and L4-L5 for adult
stages were acutely dissected in ice cold Phosphate buff-
ered saline (PBS). TrkA null mutant mice (Smeyne et al.,
1994) were generated by breeding heterozygotes (C57Bl6
background).
SAGE Library construction and data analysis
SAGE libraries were made on lumbar wild-type and TrkA
mutant mice DRGs (approximately 80–100,000 cells)
using the I-SAGE™ Kit (Invitrogen, France) according to
the manufacturer's protocol and as described previously
[11]. Mutant mice were genotyped by PCR before DRG
samples are pooled for RNA isolation. Briefly, tissues were
transferred in 100 µl of Lysis binding buffer and carefully
crushed in a 1 ml dounce homogeniser. Double strand
cDNA was synthesised from mRNA using oligo (dT)25 as
primer for the first strand synthesis and was digested with
the sequence specific anchoring restriction enzyme Nla
III. cDNA was divided in two fractions and ligated with
two adapters A and B containing cohesive 4 bp overhangs
complementary to the Nla III digested cDNA, a tagging
enzyme BsmfI recognition site at the 3' end and priming
sites for PCR amplification. Subsequent digestion with
BsmfI released adapters with an anchored short piece of
cDNA (10–14 bp) corresponding to a unique sequence
from a single transcript. After blunt-ending of tags the two
fractions of tags were ligated to form 110 bp ditags. Ditags
were then amplified in a large scale PCR and 26 bp ditags
were recovered after Nla III digestion, and polyacrylamide
gel purification. Ditags were then concatenated by self
ligation, gel purified and then cloned into pZERO-1 vec-
tor to obtain a SAGE library. About 1000 randomly
selected clones were sequenced for each library (Genome
Express, France). The number of tags per clone was
between 30 and 45. Several improvements of the classical
protocol were made [32-34].
The analysis of the generated data, and in particular,
sequence data analysis assessing the quality of the library,
extraction of tag sequences from concatemers, their anno-
tations and the analysis of their distributions was carried
out using bioinformatic tools developed by the company
Skuld-tech [18] as previously described [11]. Calculation
of P-values for the statistical significance of the differences
in tag frequencies for given genes between two SAGE
libraries was performed as described previously [35].
Quantitative RT-PCR
Quantitative RT-PCR was conducted as previously
described [11]. Briefly, total RNA was extracted from P0
wild-type and Trka mutant mice lumbar DRG in TriRea-
gent solution (Sigma), quantified by optical densitometry
and its integrity was checked by electrophoresis on agar-
ose gels. Total RNA was DNase treated with RQ1 DNase
(Promega) according to manufacturer's instructions. 1 µg
of total RNA was reverse-transcribed 1 hour at 37°C with
100 U of Superscript II reverse transcriptase (Invitrogen)
and 5 µM hexamer random primers (Roche), 0,5 mM of
each dNTPs (Invitrogen), 10 mM of dithiothreitol and 20
U of recombinant RNase inhibitor (Promega). Real time
PCR was performed by using SYBR Green I dye detection
on the LightCycler system (Roche Molecular Biochem-
ichals). PCR reactions were carried out in a 10 µl volume
containing 3 µl of RT product (final dilution 1/30), 0,5
µM of forward and reverse primers, and 5 µl of QuantiTect
SYBR Green PCR Master Mix (Qiagen). After an initial
activation step of 15 min at 95°C, 45 cycles consisting of
94°C for 15s, 55°C for 20 sec and 72°C for 35 sec were
performed. The identity of RT-PCR amplified products
was confirmed by sequencing (Genome express, France)
and routinely by finishing PCR runs with a melting curve
analysis (70°C to 95°C at 0,2°C increments).
The following primer pairs were used to generate the PCR
products
TrkA (primers detect all of the 4 known TrkA transcript
variants; [GenBank:XM_986774, XM_986810,
XM_986852, XM_986890]:
s- TGGCAGTTCTCTTTCCCCTA; as- AAAGCTCCACA-
CATCGCTCTBMC Neuroscience 2007, 8:97 http://www.biomedcentral.com/1471-2202/8/97
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Grik1/GluR5 [GenBank:NM_146072]:
s- CACATTCAGACTCGCTGGAA; as- CTCCTTGAGCA-
GAGGTTTGG
Dok4 [GenBank:NM_053246]:
s- CACTGTCCGTGGAATGTCTG; as- GGTAAAGCGCG-
TAGCATCTC
Crip2 [GenBank:NM_024223]:
s- AGGCACAGTTCAGCCCTAGA; as- GGACAGTCACCTT-
GGAGAGC
Ube2e3 [GenBank:NM_009454]:
s- TGCTGGGCCTAAAGGAGATA; as- TCCCTGACTGTT-
GATGTTGC
Polr2j [GenBank:NM_011293]:
s- ACCACACTCTGGGGAACATC; as- CTCGCTGATGAG-
GTCTGTGA
Ddx48 [GenBank:NM_138669]:
s- GGAGTTAGCGGTGCAGATTC; as- AGCATCTTGAT-
AGCCCGTGT
The relative amounts of specifically amplified cDNAs were
calculated using the delta-CT method [36,37] on three
independent experimental replicates after normalisation
by two stable control genes (polymerase (RNA) II
polypeptide J, polr2j and DEAD box polypeptide 48,
Ddx48). The Mann Whitney U-test was used for compari-
son between groups. p value < 0,05 were considered sta-
tistically significant.
Amplification of selected genes by RT-PCR and DIG-
labeled riboprobe synthesis
PCR products of 400–800 bps were amplified from wild-
type mouse cortex or DRG cDNA as template, using prim-
ers designed using the Primer 3 software [38], in a 20 µl
reaction using Platinum Taq polymerase (Invitrogen)
under standard conditions. All PCR products used in sub-
sequent experiments were sequenced (Millegene, France).
The following primer pairs were used to generate the PCR
products of about 500 base-pairs:
TrkA (primers detect all of the 4 known TrkA transcript
variants; [GenBank:XM_986774, XM_986810,
XM_986852, XM_986890]:
s-TGGCAGTTCTCTTTCCCCT; as-AAAGCTCCACA-
CATCGCTCT
Scn10a [GenBank:NM_009134]:
s-GAACCTGACAAAGCCAGCTC; as-AATGCGGTAACAG-
GTTTTGC
CGRP [GenBank:NM_001033954]:
s-TGGTTGTCAGCATCTTGCTC; as-CAACACGAT-
GCACAATAGGC
Grik1/GluR5 [GenBank:NM_146072]:
s-GAATGACAAAGGGGAGTGGA; as-AAGGTCATTGTC-
GAGCCA
Crip2 [GenBank:NM_024223]:
s-CCTCCAAGTGTCCCAAGTGT; as-CTGAGGCAG-
GACTAGGCAAC
Dok4 [GenBank:NM_053246]:
s-TCGTCAAGCAAGGCTATGTG; as-CTGTGAACCCGCT-
GGTAAAT
PCR products were ligated into the pGEM-T easy vector
using the TA cloning kit (Promega) and manufacturer's
instructions. In order to generate PCR products carrying
the T7 promoter in an appropriate orientation to generate
antisense DIG riboprobes, a second PCR amplification
was carried out on the above ligation mix using the sense
primer for the gene of interest and the M13forward primer
located downstream of the T7 promoter sequence in the
pGEM-T easy vector. The resulting PCR product contains
the T7 RNA polymerase promoter sequence downstream
of the cDNA fragment. Antisense DIG probes were gener-
ated in a 5 µl reaction containing 100–200 ng PCR prod-
ucts and using DIG RNA labeling mix (Roche) and T7
RNA polymerase (Invitrogen) following the manufac-
turer's instructions. DIG-labeled riboprobe was ethanol-
precipitated with LiCL, washed with 70% ethanol and
resuspended in water.
In situ hybridisation on cryostat sections of DRG
L3-L6 DRG from P0 wild-type and TrkA mutant mice and
adult mice were dissected out separately in PBS and fixed
in 2% paraformaldehyde (PFA) for 1 h at RT and cryopre-
served in 25% sucrose overnight at 4°C before embedding
in OCT compound (Tissue-Tek). Sections of 12 µm were
cut on a cryostat, collected on ProbeOn Plus microscope
slides (Fisher Scientific) and store at -80°C until used.BMC Neuroscience 2007, 8:97 http://www.biomedcentral.com/1471-2202/8/97
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In situ hybridizations were performed essentially as
described in [39]. After hybridization overnight at 65°C
with a riboprobe, the slices were washed twice in 1× SSC,
50% formamide, and 0.1% Tween-20 at 65°C for 30 min
and blocked in the presence of 2% blocking reagent and
20% inactivated sheep serum. The slides were then incu-
bated with anti-DIG-alkaline-phosphatase (AP)-conju-
gated antibody (Roche Diagnostics), washed and revealed
with NBT/BCIP staining.
Double in situ hybridization/immunhistochemistry
Double in situ hybridizations were performed on 12 µm
thick frozen sections prepared as above. DIG- and Fluo-
labeled probes were mixed in hybridization buffer and
applied to sections. After hybridization at 65°C overnight,
sections were washed twice in 50% Formamide, 1× SSC,
0.1% Tween-20 for 1 h at 65°C, twice in MABT buffer for
30 min before blocking in blocking buffer (MABT, 2%
blocking reagent from Roche, 20% inactivared sheep
serum) for 2 h at room temperature. Sections were then
exposed to a 1:2000 dilution of anti-Fluo-alkaline phos-
phatase (AP)-conjugate antibody (Roche) in blocking
buffer overnight at 4°C. After washing for 30 min in
MABT, the bound Fluo-probe was visualized by an AP-cat-
alyzed color reaction using Fast Red tablets (Roche)
according to the manufacturer's instructions. The color
reaction was stopped in water, the slides were mounted
temporarily in 90% glycerol and 0.1 M Tris, pH 8.2 and
the images were acquired on a Zeiss Axioskop using
Samba software. After washing for 15 min in 0.1 M Tris
pH 8.2, the AP activity was then inactivated by incubating
with 100 mM glycine and 0.1% Tween-20, pH 2.2, for 30
min. The sections were washed twice in PBS, 0.1% Tween-
20 for 15 min, post-fixed in 4% PFA in PBS for 10 min at
room temperature, washed in PBS, 0.1% Tween-20 for 20
min, twice in MABT buffer for 30 min, blocked again in
blocking buffer for 2 h, and incubated overnight with
anti-DIG-AP conjugate antibody (Roche) at 4°C. After
washing as above, slides were incubated this time with
NBT-BCIP (Roche) staining solution according to the
manufacturer's instructions and the reaction stopped by
washing in water. Fast Red precipitates were then removed
by incubating the slides in increasing concentrations of
ethanol, culminating in two final incubations in 100%
ethanol for 10 min. Photographs of the NBT/BCIP results
were then taken for comparison with those showing the
Fast Red results on the same sections. The Fast Red signals
were converted into pseudo-red and the NBT/BCIP signals
into pseudo-green fluorescent colour. The pseudo-red flu-
orescent images were then carefully overlaid with pseudo-
green fluorescent images. This sequential approach per-
mits unequivocal identification of coexpression at the sin-
gle cell level.
For double staining with isolectin B4, in situ hybridiza-
tion with digoxigenin (DIG)-labeled probe was first per-
formed. The cryostat sections were blocked in 1% BSA
plus 0.1% Triton in PBS for 1 h, followed by staining with
IB4-Biotin (10 mg/ml, Sigma) and ExtrAvidin-FITC conju-
gated (Sigma). After acquisition of fluorescent images, the
sections were blocked with 20% sheep serum, incubated
with alkaline phosphatase (AP)-conjugated sheep anti-
DIG antibody (Roche), followed by AP reaction with
NBT/BCIP substrate to label mRNA. The in situ hybridisa-
tion signals were then photographed under translumines-
cent light and converted into pseudo-red fluorescent
colour. The IB4+ fluorescent images (green) and in situ
images (red) were overlaid to reveal co-labelled cells.
Cell counting
To determine the percentages of neurons expressing
molecular markers, only cells with neuronal morphology
and clearly identifiable nuclei were counted manually. A
minimum of 4 sections from DRGs were counted and the
average numbers of labelled neurons over total numbers
of neurons was calculated.
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